Skip to content

Clinical trials

Completed Phase 1/2 Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Phase 1/2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20052
20082
20091
20101
20111
20132
20141
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Asan Medical Center1
Cancer Treatment Centers of America1
Constellation Pharmaceuticals1
Inge Marie Svane1
Italfarmaco1
Mayo Clinic1
NS Pharma, Inc.1
Novartis Pharmaceuticals1
OHSU Knight Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential16
Myeloproliferative Disorders14
Polycythemia Vera14
Primary Myelofibrosis13
Leukemia, Myeloid, Acute9
Leukemia8
Myelodysplastic Syndromes8
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Myelomonocytic, Chronic6
Blast Crisis5

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.